Search

Possible new treatment for Alzheimer’s disease: cautious optimism

2 Jan 2020 - 11:30

Biogen presented trial data last year, November, at the Clinical Trials on Alzheimer’s Disease conference in San Diego, for their drug aducanumab.

It was noted that this is a new analysis of data from trials previously stopped prematurely due to limited likelihood of success, so some are advising caution in the interpretation of results.

Read the full story here.

Contact Us

T: 021 406 6829

HIV & TB HCW Hotline: 0800 212 506 or 021 406 6782

Please Call Me/SMS: 071 840 1572

E-mail: pha-mic@uct.ac.za

The information shared on these pages is intended for use by health professionals. It has been compiled from information available to the National HIV & TB Health Care Worker Hotline based at the Medicines Information Centre, and although the greatest care has been taken, the Medicines Information Centre does not accept responsibility for errors or omissions.